Transcutaneous Auricular Vagus Nerve Stimulation in Dry Eye Disease

Recruiting now · Phase 2

Conditions studied: Dry Eye Disease

In brief

Objective: To evaluate the effect of transcutaneous auricular vagus nerve stimulation (taVNS) for the patients with dry eye disease with meibomian gland dysfunction. Methods: We enrolled 256 patients at Beijing Tongren Hospital. Patients completed questionnaires at baseline, 1 month, 3 months, and 6 months.OSDI score, TBUT, Schirmer I, tCFS, MGD score, and psychological status to evaluate the therapeutic effects. A difference of P \< 0.05 was considered statistically significant.

Key facts

Study ID

NCT04673643

Run by

Beijing Tongren Hospital

People needed

128

Starts

2021-07-01

Expected to finish

2024-10-20

Last updated by the study team

2024-09-19

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age >=18 and Age <=75.
• Clinical diagnosis of dry eye disease.

You may not qualify if…

• History of depression, tumors, thyroid disease, diabetes, cardiac diseases.
• History of phthalmology surgery.
• Pregnant or lactating women.

Where it is running

• Beijing Tongren Hospital — Beijing, China (enrolling)
• Wu Dong — Beijing, China

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.